Amneal Pharmaceuticals has started shipping a drug used to treat opioid dependence, the company said Tuesday.
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a drug to treat opioid dependence.
The Generic Pharmaceutical Association re-elected its chairman from last year and appointed a new board of directors for 2013 whose members run from A to Z — as in Amneal to Zydus.
U.S. generic drug maker Amneal Pharmaceuticals has entered a deal with South Korean drug maker Hanmi Pharmaceutical to acquire exclusive distribution rights for a Hanmi drug used for treating gastroesophageal reflux disease, Amneal said Monday.
Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.
Generic drug maker Amneal Pharmaceuticals will spend $120 million to expand three of its plants, the company said Monday.
Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.
Amneal Pharmaceuticals has launched a generic version of an antidepressant made by Forest Labs.
Amneal Pharmaceuticals has launched its generic version of a drug designed to treat seizures in adults and children with epilepsy.
Generic drug maker Amneal Pharmaceuticals has added four new executives, the company said.
Chirag Patel and Chintu Patel, who respectively are the president and CEO of Amneal Pharmaceuticals, recently received the Ernst & Young Entrepreneur of the Year award.
Shire has filed patent infringement suits against two generic drug makers relating to its attention deficit hyperactivity disorder treatment.
A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.
The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.
Amneal Pharmaceuticals has named a drug industry attorney as SVP and general counsel, the generic drug maker said Thursday.
The Food and Drug Administration has approved a generic treatment for hypertension and liver cirrhosis...
Generic drug maker Amneal Pharmaceuticals has appointed a former Par Pharmaceutical Cos. executive as chief...
The Food and Drug Administration has approved a generic drug for anxiety disorder made by...
Generic drug maker Amneal Pharmaceuticals plans to invest more than $6.6 million in its sales...